Precision Medicine is a concept for prevention and treatment that takes into account individual variability in genetic predispositions, environmental influences, and lifestyles. It gives rise to more accurate prevention and treatment strategies for particular diseases, instead of the traditional one-size-fits-all therapy regimes.
The seminar will examine the impact of individualized medicine on our resilience as humans in a world where so-called ‘diseases of civilization’ are mounting. It will also discuss the critical social challenges of delivering universal access to precision medicine.
Mohamed ABOU EL-ENEIN
Head, Clinical Development Platform, Berlin-Brandenburg Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin|
Professor and Research, Department of Pharmaceutics, Ain Shams University, Cairo|
Head, Clinical Development Platform, Berlin-Brandenburg Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin
| ||Dr. Abou-El-Enein is a professor of regenerative medicine, head of the clinical development platform at the BCRT, Charité University Hospital. The platform is responsible for transforming the research findings of the scientists into clinical applications. He is Instructor in Translational Medicine and Regulatory Science at the Berlin-Brandenburg School for Regenerative Therapies (BSRT) and serves as a senior Teaching Assistant in clinical research at Harvard T.H. Chan School of Public Health. He earned his medical degree from Mansoura Faculty of Medicine and has specialized training in Health Care Quality Management at the American University in Cairo. He received a MsT in Pharmaceutical Sciences and Biotechnologies from Strasbourg University, a Clinical Research Certificate from Harvard Medical School and a Doctoral Degree in Economics Research for Cellular Therapies from Charité University Hospital. His primary research interest focuses on the development and clinical translation of cell and gene therapies where he has succeeded to bring numerous advanced therapies into early phase clinical trials. He has strong interest in global health and the equitable access to health care.|
Professor and Research, Department of Pharmaceutics, Ain Shams University, Cairo
|2008-2012 Assistant Lecturer, Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy Ain Shams University, Cairo|
|2011 Visiting Scientist and Researcher, School of Pharmacy and Biomedical Sciences; Institute of Nanotechnology and Bioengineering, University of Central Lancashire|
|2012-2017 Assistant Professor, Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy Ain Shams University, Cairo|
|2013 Postdoctoral Fellow, Division of Drug delivery Technology, Leiden Academic Center for Drug Research, Leiden|
|2015 Visiting Scientist, Centre for Pharmaceutical Engineering Science, University of Bradford|
|since 2017 Associate Professor, Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo|